Structural Comparison of Firefly Luciferase with the Latent Luciferase CG6178

Celia Schiffer , Markus Bohn , Stephen Miller , Spencer Adams
The FASEB Journal 29

2015
Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia.

Sebastian Maurer-Stroh , Sebastian Maurer-Stroh , Charles S. Craik , Olivier Terrier
Cell

56
2021
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

David E Gordon , Gwendolyn M Jang , Mehdi Bouhaddou , Jiewei Xu
Nature 583 ( 7816) 459 -468

3,580
2020
Epitopes of sars-cov-2 neutralizing antibodies

Yifan Cheng , Daniel Asarnow , Charles Craik , Aashish Manglik

2021
Specificity for latent C termini links the E3 ubiquitin ligase CHIP to caspases.

Matthew Ravalin , Panagiotis Theofilas , Koli Basu , Kwadwo A. Opoku-Nsiah
Nature Chemical Biology 15 ( 8) 786 -794

13
2019
Global substrate specificity profiling of post-translational modifying enzymes.

Sam L. Ivry , Nicole O. Meyer , Michael B. Winter , Markus F. Bohn
Protein Science 27 ( 3) 584 -594

15
2018
Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity.

Takahide Kouno , Tania V. Silvas , Brendan J. Hilbert , Shivender M. D. Shandilya
Nature Communications 8 ( 1) 15024 -15024

82
2017
Phage display assisted discovery of a pH‐dependent anti‐α‐cobratoxin antibody from a natural variable domain library

Tulika Tulika , Rasmus W Pedersen , Charlotte Rimbault , Shirin Ahmadi
Protein Science 32 ( 12) e4821 -e4821

3
2023
Allosteric Inhibitors, Crystallography, and Comparative Analysis Reveal Network of Coordinated Movement across Human Herpesvirus Proteases.

Timothy M. Acker , Jonathan E. Gable , Markus-Frederik Bohn , Priyadarshini Jaishankar
Journal of the American Chemical Society 139 ( 34) 11650 -11653

7
2017
REdiii: a pipeline for automated structure solution

Markus-Frederik Bohn , Celia A. Schiffer
Acta Crystallographica Section D-biological Crystallography 71 ( 5) 1059 -1067

1
2015
Crystal Structure of the DNA Cytosine Deaminase APOBEC3F: The Catalytically Active and HIV-1 Vif-Binding Domain

Markus-Frederik Bohn , Shivender M.D. Shandilya , John S. Albin , Takahide Kouno
Structure 21 ( 6) 1042 -1050

83
2013
The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization

Markus-Frederik Bohn , Shivender M.D. Shandilya , Tania V. Silvas , Ellen A. Nalivaika
Structure 23 ( 5) 903 -911

66
2015
Structural Determination of the Broadly Reactive Anti-IGHV1-69 Anti-idiotypic Antibody G6 and Its Idiotope

Yuval Avnir , Kristina L. Prachanronarong , Zhen Zhang , Shurong Hou
Cell Reports 21 ( 11) 3243 -3255

9
2017
Methylcytosine and Normal Cytosine Deamination by the Foreign DNA Restriction Enzyme APOBEC3A

Michael A. Carpenter , Ming Li , Anurag Rathore , Lela Lackey
Journal of Biological Chemistry 287 ( 41) 34801 -34808

101
2012
A computational analysis of the structural determinants of APOBEC3's catalytic activity and vulnerability to HIV-1 Vif.

Shivender M.D. Shandilya , Markus-Frederik Bohn , Celia A. Schiffer
Virology 105 -116

20
2014
Ehlers-Danlos Syndrome Caused by Biallelic TNXB Variants in Patients with Congenital Adrenal Hyperplasia.

Wuyan Chen , Ashley F. Perritt , Rachel Morissette , Jennifer L. Dreiling
Human Mutation 37 ( 9) 893 -897

17
2016
A covalent inhibitor of K-Ras (G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy

Ziyang Zhang , Peter J Rohweder , Chayanid Ongpipattanakul , Koli Basu
Cancer Cell 40 ( 9) 1060 -1069

11
2022
The challenges with developing therapeutic monoclonal antibodies for pandemic application

Andreas H Laustsen , Markus-Frederik Bohn , Anne Ljungars
Expert Opinion on Drug Discovery 17 ( 1) 5 -8

2
2022